Related references
Note: Only part of the references are listed.Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy
Cedric Duron et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Niels Vande Casteele et al.
GASTROENTEROLOGY (2015)
Incidence and Management of Infusion Reactions to Infliximab in a Prospective Real-world Community Registry
Denis Choquette et al.
JOURNAL OF RHEUMATOLOGY (2015)
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
Niels Vande Casteele et al.
GUT (2015)
Antibodies to Infliximab and Risk of Infusion Reactions in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Sorcha O'Meara et al.
INFLAMMATORY BOWEL DISEASES (2014)
Tolerability of one hour 10 mg/kg infliximab infusions in inflammatory bowel diseases: A prospective multicenter cohort study
Abdenour Babouri et al.
JOURNAL OF CROHNS & COLITIS (2014)
The Effect of Defaults in an Electronic Health Record on Laboratory Test Ordering Practices for Pediatric Patients
C. Adam Probst et al.
HEALTH PSYCHOLOGY (2013)
Five Things Physicians and Patients Should Question in Hospice and Palliative Medicine
Daniel Fischberg et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2013)
Variation in Infliximab Administration Practices in the Treatment of Pediatric Inflammatory Bowel Disease
Jeremy Adler et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2013)
Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease
C. Steenholdt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study
T. W. Lee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Tolerability of Shortened Infliximab Infusion Times in Patients With Inflammatory Bowel Diseases: A Single-Center Cohort Study
Christine Breynaert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Review and expert opinion on prevention and treatment of infliximab-related infusion reactions
L. L. A. Lecluse et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Premedication and infusion reactions with infliximab: Results from a pediatric inflammatory bowel disease consortium
DA Jacobstein et al.
INFLAMMATORY BOWEL DISEASES (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
RJ Farrell et al.
GASTROENTEROLOGY (2003)
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
F Baert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Infliximab for Crohn's disease in clinical practice at the mayo clinic: The first 100 patients
E Ricart et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)
Share Paper
